ACHIEVE CLEAR CELL RENAL CELL CARCINOMA (CCRCC) CURES THROUGH DUAL-TARGETED FINE-TUNED IMMUNE RESTORING (DFIR) CAR-T CELL THERAPY Breadcrumbs UL Home Research Publications Year of Publication 2021 Journal Cytotherapy DOI 10.1016/S1465324921004126